Medical-Legal News

F.D.A. to Restrict Avandia, Citing Heart Risk (09/23/2010)

In a highly unusual coordinated announcement, drug regulators in Europe and the United States said Thursday that Avandia, the controversial diabetes medicine, would no longer be widely available.

The drug’s sales will be suspended entirely in Europe, while patients in the United States will be allowed access to the medicine only if they and their doctors attest that they have tried every other diabetes medicine and that patients have been made aware of the drug’s substantial risks to the heart. Patients now taking Avandia may continue to do so. (See Full Article Here)

Hospital Settles Brain Damaged Newborn Case for $11mm (09/22/2010

Tripler Army Medical Center paid $11 million to a family whose baby suffered permanent brain damage during delivery in 2005, attorneys for the family announced this week. (See Full Article Here)

Payment Disclosure by Docs to Medical Journals Poor (09/14/2010)

Many surgeons fail to disclose their financial ties to orthopedics device companies, according to an article published this week in the Archives of Internal Medicine. Co-author Dr. David Rothman of the Institute on Medicine as a Profession notes that close to 50 percent of surgeons who were paid $1 million or more by one of five device companies examined did not disclose such ties when publishing articles in various medical journals.  (See Full Article Here)

Bone Morphogenetic Proteins Used Off-Label in 85% of Cases (09/09/2010)

A new study in Spine documents the rise of BMPs and the prevalence of off-label use, demonstrating that between 2003 and 2007, the annual number of procedures utilizing BMPs increased 4.3-fold from 23,900 to 103,194. Of those, 85% were identified as off-label uses of the material. The data came from the Nationwide Inpatient Sample, which the paper touts as the “single largest all-payer inpatient care database in the United States.” (See the Full Article Here)

AMA Malpractice Survey Reveals Docs Most at Risk (08/04/2010)

Statistically speaking, 95 out of every 100 physicians practicing in the United States will be sued for medical malpractice sometime in their career, according to a report released yesterday from the American Medical Association (AMA). (See Full Article Here)

Panel Urges FDA to Revoke Approval of Avastin for Breast Cancer Treatment (07/20/2010)

An advisory committee recommended Tuesday that the Food and Drug Administration revoke approval of the drug Avastin as a treatment for breast cancer, saying the drug was not helping patients. (See Full Article Here)

F.D.A. Steps Up Oversight of Infusion Pumps (04/23/2010)

Federal regulators say they are moving to tighten their oversight of medical devices, including one of the most ubiquitous and problematic pieces of medical equipment — automated pumps that intravenously deliver drugs, food and other solutions to patients. (See Full Article Here)

Concerns Over ‘Metal on Metal’ Hip Implants (03/03/2010)

Some of the nation’s leading orthopedic surgeons have reduced or stopped use of a popular category of artificial hips amid concerns that the devices are causing severe tissue and bone damage in some patients, often requiring replacement surgery within a year or two. (See Full Article Here)

Ohio Medical Malpractice Premiums Keep Dropping (01/09/2010)

Medical malpractice premiums in Ohio have continued to fall for the fourth straight year, a trend which both state regulators and insurers attribute to a mix of policy changes, liability limits and safety initiatives. (See Full Article Here)